Home
Why Open Innovation
What We Offer
Strategy
Implementation
OI Intermediary
Unique Insight
How We Work
OI Resources
Our News
About Us
Contact Us
Our News
Update to: Innovahealth Final Report now available
Jackie Hunter invited to chair 2nd evaluation of the IMI
Follow Us
"By adopting a more “Open Innovation” agenda, GSK is adapting its business model to find new solutions"
Andrew Witty, CEO, GSK
Privacy Policy
|
Terms and Conditions
webcentric
web design cambridge
Andrew Witty, CEO, GSK